Patents by Inventor Nicholas Moss

Nicholas Moss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11913228
    Abstract: Building panel assemblies for use in the construction of new homes, commercial buildings and extensions having rectangular structural insulated panel (SIP) (10), comprises a pair of spaced-apart containment boards (12?,12?) an inner insulating core (13) and a low profile peripheral external rigid frame (14), preferably of metal, e.g. steel, extending around the entire periphery of the spaced-apart boards (12?,12?).
    Type: Grant
    Filed: November 15, 2019
    Date of Patent: February 27, 2024
    Assignee: 4WALL IP DMCC
    Inventors: Nicholas Edwards, Christopher Moss
  • Publication number: 20220107269
    Abstract: A refractometer includes an enclosure, a single use prism, a light source, and an index of refraction (IoR) sensor. The single use prism is removably disposed within the enclosure. The light source and IoR sensor are disposed within the housing and are configured to be repeatably used with a series of single use prisms of similar construction. One single use prism can be removed after being used, and a new single use prism can be installed in the enclosure for use with the same light source and IoR sensor as were used with the first prism.
    Type: Application
    Filed: October 2, 2020
    Publication date: April 7, 2022
    Inventors: Marios LIAROMMATIS, Nicholas MOSS
  • Publication number: 20200368629
    Abstract: A remote-control vehicle is disclosed. The vehicle comprises a first wheel and a second wheel offset along the longitudinal axis of the vehicle. The vehicle further comprises a device adapted to apply a torque to the first wheel, a sensor configured to monitor the pitch angle of the vehicle, and a control module. The control module is configured to control the torque applied by the device to the first wheel in accordance with the monitored vehicle pitch angle so as to accelerate the vehicle while maintaining the vehicle pitch angle within a range of acute angles.
    Type: Application
    Filed: November 21, 2018
    Publication date: November 26, 2020
    Inventor: Nicholas Moss
  • Patent number: 10422716
    Abstract: Methods and systems for leak testing flexible expandable bags are disclosed.
    Type: Grant
    Filed: December 8, 2016
    Date of Patent: September 24, 2019
    Assignee: Pall Corporation
    Inventors: Nicholas Moss, Robin Hodges
  • Publication number: 20180164180
    Abstract: Methods and systems for leak testing flexible expandable bags are disclosed.
    Type: Application
    Filed: December 8, 2016
    Publication date: June 14, 2018
    Inventors: Nicholas Moss, Robin Hodges
  • Publication number: 20170096641
    Abstract: Hepatic progenitors comprise two populations of human hepatic stem cells, primitive and proximal hepatic stem cells, and two populations of committed progenitors, one for biliary cells and one for hepatocytes. Human primitive hepatic stem cells are a very small fraction of the liver cell population and give rise to proximal hepatic stem cells constituting a much larger fraction of the liver. Human proximal hepatic stem cells give rise to biliary and hepatocyte committed progenitors. Primitive and proximal stem cells are the primary stem cells for the human liver. Human primitive hepatic stem cells may be isolated by immunoselection from human livers or culturing human liver cells under conditions which select for a human primitive hepatic stem cell. Proximal hepatic stem cells may be isolated by immunoselection, or by culturing human liver cells under conditions which include a developmental factor.
    Type: Application
    Filed: October 12, 2016
    Publication date: April 6, 2017
    Applicants: Vesta Therapeutics Inc., University of North Carolina at Chapel Hill
    Inventors: Lola M. REID, Nicholas MOSS, Mark E. FURTH, John W. LUDLOW, Andrew T. BRUCE
  • Publication number: 20140302601
    Abstract: Hepatic progenitors comprise two populations of human hepatic stem cells, primitive and proximal hepatic stem cells, and two populations of committed progenitors, one for biliary cells and one for hepatocytes. Human primitive hepatic stem cells are a very small fraction of the liver cell population and give rise to proximal hepatic stem cells constituting a much larger fraction of the liver. Human proximal hepatic stem cells give rise to biliary and hepatocyte committed progenitors. Primitive and proximal stem cells are the primary stem cells for the human liver. Human primitive hepatic stem cells may be isolated by immunoselection from human livers or culturing human liver cells under conditions which select for a human primitive hepatic stem cell. Proximal hepatic stem cells may be isolated by immunoselection, or by culturing human liver cells under conditions which include a developmental factor.
    Type: Application
    Filed: April 3, 2014
    Publication date: October 9, 2014
    Applicants: University of North Carolina at Chapel Hill, Vesta Therapeutics Inc.
    Inventors: Lola M. REID, Nicholas MOSS, Mark E. FURTH, John W. LUDLOW, Andrew T. BRUCE
  • Patent number: 8691523
    Abstract: Hepatic progenitors comprise two populations of human hepatic stem cells, primitive and proximal hepatic stem cells, and two populations of committed progenitors, one for biliary cells and one for hepatocytes. Human primitive hepatic stem cells are a very small fraction of the liver cell population and give rise to proximal hepatic stem cells constituting a much larger fraction of the liver. Human proximal hepatic stem cells give rise to biliary and hepatocyte committed progenitors. Primitive and proximal stem cells are the primary stem cells for the human liver. Human primitive hepatic stem cells may be isolated by immunoselection from human livers or culturing human liver cells under conditions which select for a human primitive hepatic stem cell. Proximal hepatic stem cells may be isolated by immunoselection, or by culturing human liver cells under conditions which include a developmental factor.
    Type: Grant
    Filed: December 12, 2006
    Date of Patent: April 8, 2014
    Assignees: Vesta Therapeautics, Inc., University of North Carolina at Chapel Hill
    Inventors: Lola M. Reid, Nicholas Moss, Mark E. Furth, John W. Ludlow, Andrew T. Bruce
  • Publication number: 20100197015
    Abstract: Methods of isolating and cryopreserving progenitors from human liver are disclosed which include processing human liver tissue to provide a substantially single cell suspension comprising progenitors and non-progenitors of one or more cell lineages found in human liver; subjecting the suspension to a debulking step, which reduces substantially the number of non-progenitors in the suspension, and which provides a debulked suspension enriched in progenitors exhibiting one or more markers associated with at least one of the one or more cell lineages; and selecting from said debulked suspension those cells, which themselves, their progeny, or more mature forms thereof express one or more markers associated with at least one of the one or more cell lineages. Among these markers are CD14, CD34, CD38, CD45, and ICAM. Hepatic progenitors are characterized as being 6-15? in diameter, diploid, glycophorin A?, CD45?, AFP+++, ALB+, ICAM+, and with subpopulations varying in expression of CD14+. CD34++, CD38++, CD117+.
    Type: Application
    Filed: January 28, 2010
    Publication date: August 5, 2010
    Inventors: Lola M. Reid, Nicholas Moss, Hiroshi Kubota
  • Patent number: 7413897
    Abstract: Hepatic progenitors comprise two populations of human hepatic stem cells, primitive and proximal hepatic stem cells, and two populations of committed progenitors, one for biliary cells and one for hepatocytes. Human primitive hepatic stem cells are a very small fraction of the liver cell population and give rise to proximal hepatic stem cells constituting a much larger fraction of the liver. Human proximal hepatic stem cells give rise to biliary and hepatocyte committed progenitors. Primitive and proximal stem cells are the primary stem cells for the human liver. Human primitive hepatic stem cells may be isolated by immunoselection from human livers or culturing human liver cells under conditions which select for a human primitive hepatic stem cell. Proximal hepatic stem cells may be isolated by immunoselection, or by culturing human liver cells under conditions which include a developmental factor.
    Type: Grant
    Filed: March 14, 2003
    Date of Patent: August 19, 2008
    Assignees: University of North Carolina at Chapel Hill, Vesta Therapeutics, Inc.
    Inventors: Lola M. Reid, Nicholas Moss, Mark Furth, John W. Ludlow, Andrew T. Bruce
  • Publication number: 20050148072
    Abstract: Methods of isolating and cryopreserving progenitors from human liver are disclosed which include processing human liver tissue to provide a substantially single cell suspension comprising progenitors and non-progenitors of one or more cell lineages found in human liver; subjecting the suspension to a debulking step, which reduces substantially the number of non-progenitors in the suspension, and which provides a debulked suspension enriched in progenitors exhibiting one or more markers associated with at least one of the one or more cell lineages; and selecting from said debulked suspension those cells, which themselves, their progeny, or more mature forms thereof express one or more markers associated with at least one of the one or more cell lineages. Among these markers are CD14, CD34, CD38, CD45, and ICAM. Hepatic progenitors are characterized as being 6-15? in diameter, diploid, glycophorin A?, CD45?, AFP+++, ALB+, ICAM+, and with subpopulations varying in expression of CD14+. CD34++, CD38++, CD117+.
    Type: Application
    Filed: September 21, 2004
    Publication date: July 7, 2005
    Applicant: The University of North Carolina at Chapel Hill
    Inventors: Lola Reid, Nicholas Moss, Hiroshi Kubota
  • Publication number: 20020182188
    Abstract: Methods of isolating and cryopreserving progenitors from human liver are disclosed which include processing human liver tissue to provide a substantially single cell suspension comprising progenitors and non-progenitors of one or more cell lineages found in human liver; subjecting the suspension to a debulking step, which reduces substantially the number of non-progenitors in the suspension, and which provides a debulked suspension enriched in progenitors exhibiting one or more markers associated with at least one of the one or more cell lineages; and selecting from said debulked suspension those cells, which themselves, their progeny, or more mature forms thereof express one or more markers associated with at least one of the one or more cell lineages. Among these markers are CD14, CD34, CD38, CD 45, and ICAM.
    Type: Application
    Filed: January 19, 2000
    Publication date: December 5, 2002
    Inventors: Lola M. Reid, Nicholas Moss, Hiroshi Kubota